Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · Real-Time Price · USD

5.92

+0.64 (12.12%)

At close: Feb 24, 2026, 4:00 PM EST

5.92

0.00 (0.00%)

Pre-market: Feb 25, 2026, 6:17 AM EST

Sagimet Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 24, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	193	145	124	-	-	-
Market Cap Growth	26.96%	16.75%	-	-	-	-
Enterprise Value	67	-25	22	-	-	-
Last Close Price	5.92	4.50	5.42	-	-	-
PS Ratio	-	-	62.05	-	-	-
PB Ratio	1.61	0.93	1.36	-	-	-
P/TBV Ratio	1.61	0.93	1.36	-	-	-
EV/Sales Ratio	-	-	11.18	-	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.01	0.00
Net Debt / Equity Ratio	-1.05	-1.02	-1.04	-1.16	-1.00	-1.02
Net Debt / EBITDA Ratio	-	-	-	-	-	6.01
Asset Turnover	-	-	0.03	-	-	-
Quick Ratio	12.76	33.96	16.78	6.13	23.25	35.97
Current Ratio	13.06	34.30	17.09	6.21	24.04	35.99
Return on Equity (ROE)	-39.78%	-36.92%	-46.96%	-72.58%	-39.63%	-29.98%
Return on Assets (ROA)	-26.52%	-26.49%	-29.62%	-42.16%	-23.16%	-17.79%
Return on Capital Employed (ROCE)	-53.90%	-35.00%	-33.80%	-111.90%	-41.90%	-17.00%
Earnings Yield	-29.95%	-31.45%	-22.46%	-	-	-
Buyback Yield / Dilution	-10.81%	-199.71%	-5565.90%	-50.61%	-26.95%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q